Publication Name	World Journal of Gastroenterology
Manuscript ID	18546
Country	South Korea

Received	2015-04-23 08:26
Peer-Review Started	2015-04-24 15:49
To Make the First Decision	2015-05-18 12:24
Return for Revision	2015-05-22 11:20
Revised	2015-06-11 19:00
Second Decision	2015-08-19 14:49
Accepted by Journal Editor-in-Chief	2015-08-20 08:47
Accepted by Executive Editor-in-Chief	2015-08-31 17:30
Articles in Press	2015-08-31 17:30
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-09-09 17:34
Publish the Manuscript Online	2015-09-28 11:42

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Allergy
Manuscript Type	Topic Highlights
Article Title	Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system
Manuscript Source	Invited Manuscript
All Author List	Kichang Han and Jin Hyoung Kim
Funding Agency and Grant Number
Corresponding Author	Jin Hyoung Kim, MD, Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 388-1, Poongnap-2dong, Songpa-gu, Seoul 138-736, South Korea. jhkimrad@amc.seoul.kr
Key Words	Hepatocellular carcinoma; Transarterial chemoembolization; Sorafenib; Radiofrequency ablation; Hepatic resection; Liver transplantation
Core Tip	This article describes the role of transarterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC) according to the barcelona clinic liver cancer (BCLC) staging system. Notably, TACE is the treatment of choice in the treatment of intermediate HCC (BCLC stage B). However, in clinical practice, TACE has been used as an alternative or combination therapy in patients with early or advanced HCC. Therefore, diverse treatment modalities, including TACE, should be considered for the best interests of patients with HCC.
Publish Date	2015-09-28 11:42
Citation	Han K, Kim JH. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system. World J Gastroenterol 2015; 21(36): 10327-10335
URL	http://www.wjgnet.com/1007-9327/full/v21/i36/10327.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i36.10327

Full Article (PDF)	WJG-21-10327.pdf
Full Article (Word)	WJG-21-10327.doc
Manuscript File	18546-Review.docx
Answering Reviewers	18546-Answering reviewers.pdf
Audio Core Tip	18546-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	18546-Conflict-of-interest statement.pdf
Copyright License Agreement	18546-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	18546-Language certificate.pdf
Peer-review Report	18546-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	18546-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	18546-Scientific misconduct check.pdf
Scientific Editor Work List	18546-Scientific editor work list.pdf